Abridge, an Nvidia-backed healthcare AI startup valued at $5.3 billion, is introducing clinical intelligence tools directly into doctor workflows, according to CEO Doctor Rao. This innovation includes a clinical decision support feature that provides doctors with relevant patient histories and suggested questions before consultations. Abridge has developed this patient-centered clinician intelligence platform to enhance care delivery, and its collaboration with Nvidia is focused on creating a foundation model specifically designed for clinical conversations.

Abridge: Abridge develops AI-native platforms for ambient clinical documentation, decision support, and connecting care delivery with evidence-based treatment. The company recently unveiled enhancements to its clinician intelligence tools at a June 2026 keynote event in New York. It is integrating these features directly into doctor workflows to improve pre-visit preparation and patient interactions.
Shivdev Rao: Shivdev Rao, MD, is the co-founder and CEO of Abridge as well as a practicing cardiologist. He recently described new clinical decision support capabilities within the company’s product during rollout announcements. Rao emphasizes AI tools that provide medical history summaries and suggested questions ahead of patient encounters.

`json
{
“Trend”: “Healthcare AI is advancing with generative tools embedded in clinical workflows for documentation and decision support.”,
“Product”: “Abridge unveiled a patient-centered clinician intelligence platform connecting care delivery, payment, and evidence-based treatment.”
}
`